financetom
Business
financetom
/
Business
/
Gritstone bio Shares Fall Pre-Bell After Filing for Chapter 11 Restructuring
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gritstone bio Shares Fall Pre-Bell After Filing for Chapter 11 Restructuring
Oct 10, 2024 10:51 PM

06:36 AM EDT, 10/10/2024 (MT Newswires) -- Gritstone bio (GRTS) shares fell as much as 38% in recent Thursday premarket activity after the clinical-stage biotechnology company said it made a Chapter 11 filing for bankruptcy.

The company said it is filing first day motions in its Chapter 11 case and plans to continue advancing its clinical programs throughout the court-administered restructuring process.

Price: 0.1230, Change: -0.08, Percent Change: -38.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gatos Silver, First Majestic Get Regulatory Approval for Merger
Gatos Silver, First Majestic Get Regulatory Approval for Merger
Dec 16, 2024
08:32 AM EST, 12/16/2024 (MT Newswires) -- Gatos Silver ( GATO ) said Friday that the proposed acquisition of the company by First Majestic (AG) was given unconditional authorization by the Mexican Federal Economic Competition Commission. The transaction is expected to close in January. ...
Mind Medicine Doses First Patient in Phase 3 Study of MM120 to Treat Generalized Anxiety Disorder
Mind Medicine Doses First Patient in Phase 3 Study of MM120 to Treat Generalized Anxiety Disorder
Dec 16, 2024
08:35 AM EST, 12/16/2024 (MT Newswires) -- Mind Medicine (MNMD) said Monday that a first patient has been dosed in its phase 3 Voyage study that is evaluating MM120 ODT for the treatment of generalized anxiety disorder. The company said the trial is the first of two phase 3 studies evaluating the efficacy and safety of MM120 ODT versus placebo....
Biohaven Says BHV-1300 Achieves 'Deep Lowering' of Targeted IgG During Early-Stage Trial
Biohaven Says BHV-1300 Achieves 'Deep Lowering' of Targeted IgG During Early-Stage Trial
Dec 16, 2024
08:32 AM EST, 12/16/2024 (MT Newswires) -- Biohaven ( BHVN ) said Monday that its drug candidate BHV-1300 achieved deep lowering of targeted immunoglobulin G, or IgG, with reduction of more than 60% in the lowest subcutaneous dose tested during the current multiple ascending dose trial. The biopharmaceutical company said that the reduction in IgG occurred within hours of each...
Berkshire Hills Bancorp and Brookline to merge in $1.1 bln deal
Berkshire Hills Bancorp and Brookline to merge in $1.1 bln deal
Dec 16, 2024
Dec 16 (Reuters) - Regional lenders Berkshire Hills Bancorp ( BHLB ) and Brookline Bancorp ( BRKL ) have agreed to merge in an all-stock deal valued at about $1.1 billion, the companies said on Monday. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved